Wybrane wskaźniki i przeżycia depresyjnego i lęku u osób, które przeżyły nowotwór (cancer survivors)

Veronika Bolekova; Eva Nanistova; Veronika Chlebcova

doi:10.54539/sm.43

Published : 2023-07-19

Vol. 18 No. 1 (2023)

Selected indicators of depression and anxiety experience in cancer survivors

Veronika Bolekova

https://orcid.org/0000-0003-2076-1096

Eva Nanistova

https://orcid.org/0000-0001-7399-6863

Veronika Chlebcova

https://orcid.org/0000-0003-0638-9259

DOI: https://doi.org/10.54539/sm.43

Abstract

The aim of the study is to identify the most pronounced indicators of depression and anxiety in patients with delayed oncology and to link their negative emotional experiences with selected socio-demographic and clinical indicators. The research team consisted of 168 participants aged 22-83 (M = 56.01; SD = 11.97). Methods: Patient Health Questionnaire PHQ-9; Generalized anxiety disorder GAD-7. Results: Increased levels of depressive symptoms were found in 27.4% of untreated patients, with the most pronounced indicators of depressive survival being fatigue, lack of energy, and sleep disorders. About 16% of the participants showed an anxious symptomatology, which was most often manifested by diffi culty in relaxing, excessive worrying, and an inability to control worries. The degree of depression and anxiety did not signifi cantly differentiate participants' age and gender, length of time since treatment end, recurrence rate, family history of cancer, and use of supportive services and patient organizations. Higher levels of depression
and anxiety were found in participants who reported having late consequences of treatment.

Keywords:

treated cancer patients, depression, anxiety

Most read articles by the same author(s)

Eva Nanistova, Logotherapy and post-traumatic development in oncology patients , Studia Mazowieckie: Vol. 18 No. 1 (2023)

Details

References

Statistics

Authors

Download files

pdf (Język Polski)

Citation rules

Bolekova, V., Nanistova, E., & Chlebcova, V. (2023). Selected indicators of depression and anxiety experience in cancer survivors. Studia Mazowieckie, 18(1), 11–27. https://doi.org/10.54539/sm.43

Altmetric indicators

Cited By

References

Andrášiová M., Klinická psychológia v onkológii, paliatívnej starostlivosti a tanatológii, [w:] A. Heretik, A. Heretik, jr. (red.), Klinická psychológia, Psychoprof, Nové Zámky 2016.

Beekers N., Husson O., Mols F., Van Eenbergen M., Van de Poll-Franse L.V., Symptoms of Anxiety and Depression Are Associated With Satisfaction With Information Provision and Internet Use Among 3080: Cancer Survivors Results of the PROFILESR egistry „Cancer Nursing” 2015, Vol. 38, No. 5.

Blaney J.M., Lowe-Strong A., Rankin-Watt J., Campbell A., Gracey J.H., Cancer survivors ́ excercise barriers, facilitators and preference in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey, „Psycho-Oncology” 2013, nr 22. DOI:10.1002/pon.2072.

Brintzenhofe-Szoc K.M., Levin T.T., Li Y., Kissane D.W., Zabora J.R., Mixed anxiety/depression symptoms in a large cancer cohort: Prevalence by cancer type, „Psychosomatics” 2009, Vol. 50, No. 4 DOI:10.1176/appi.psy.50.4.383.

Bultz B.D., Carlson L.E., Emotional distress: the sixth vital sign in cancer care, „Journal of Clinical Oncology” 2005, nr 23.

Carlson L.E., Angen M., Cullum J., Goodey E., Koopmans J., Lamont L., MacRae J.H., Martin M., Pelletier G., Robinson J., Simpson J.S.A., Speca M., Tillotson L., Bultz B.D., High levels of untreated distress and fatigue in cancer patients, „British Journal of Cancer” 2004, 90.

Carlson L.E., Bultz B.D., Effi cacy vs. cost of psychosocial interventions: an evidencebased call for action, „Oncol Exchange” 2002, nr 1.

Clark L.A., Watson D., Tripartite Model of Anxiety and Depression: Psychometric Evidence and Taxonomic Implications, „Journal of Abnormal Psychology” 1991, Vol. 100, No. 3.

DiMatteo M.R., Lepper H.S., Croghan T.W., Depression Is a Risk Factor for Noncompliance With Medical Treatment: Meta-analysis of the Effects of Anxiety and Depression on Patient Adherence, „Arch Intern Med.” 2000, nr 160, July 24.

Hann D.M., Jacobsen P.B., Martin S.C., Kronish L.E., Azzarello L.M., Fields K.K., Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer, „Support Care Cancer” 1997, nr 5.

Hann D.M., Garovoy N., Finkelstein B., Jacobsen P.B., Azzarello L.M., Fields K.K., Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study, „J Pain Symptom Manag” 1999, nr 17.

Hewitt M., Greenfi eld Sh., Stovall E., From Cancer Patient to Cancer Survivor: Lost in Transition, The National Academies Press, Washington 2005.

Hinz A., Krauss O., Hauss J.P., Höckel M., Kortmann R.D., Stolzenburg J.U., Schwarz R., Anxiety and depression in cancer patients compared with the general population, „European Journal of Cancer Care” 2010, nr 19.

Inhestern L., Beierlein V., Bultmann J.Ch., Möller B., Romer G., Koch U., Bergelt C., Anxiety and depression in working-age cancer survivors: a register-based study, „BMC Cancer” 2017, nr 17. DOI 10.1186/s12885-017-3347-9.

Knobel H., Loge J.H., Nordoy T., Kolstad A.L., Espevik T., Kvaloy S., Kaasa S., High level of fatigue in lymphoma patients treated with high dose therapy, „J Pain Symptom Manag” 2000, nr 19.

Kroenke K., Spitzer R., Williams J., The PHQ-9: validity of a brief depression severity measure, „The Journal of General Internal Medicine” 2001, nr 16.

Linden W., Vodermaier A., MacKenzie R., Greig D., Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age, „Journal of Affective Disorders” 2012, nr 141.

Manne Sh., Schnoll R., Measuring cancer patients ́ psychological distress and wellbeing: A factor analytic assessment of the Mental Health Inventory, „Psychological Assessment” 2001, Vol. 13, No. 1. DOI: 10.1037/1040-3590.13.1.99.

Massie M.J., Prevalence of depression in patients with cancer, „J Natl Cancer Inst Monogr” 2004, nr 32. DOI:10.1093/jncimonographs/lgh014.

Mello S., Tan A.S.L., Armstrong K., Schwartz J.S., Hornik R.C., Anxiety and depression among cancer survivors: The role of engagement with sources of emotional support information, „Health Communication” 2013, Vol. 28, No. 4. DOI:10.1080/10410236.2012. 690329.

Mesárošová M., Ostró A., Psychological responses to cancer among female patients with malignant and benign breast disease, „Studia Psychologica” 2005, Vol. 47, No. 2.

MKCH-10 (10. revízia). Kapitola V, www.nczisk.sk/Standardy-v-zdravotnictve/Pages/MKCH-10-Revizia.aspx.

Morrill E.F., Brewer N.T., O ́Neil S.C., Lillie S.E., Dees E.C., Carey L.A., Rimer B.K., The interaction of posttraumatic growth and posttraumatic stress symptoms in predictiong depressive symptoms and quality of life, „Psycho-Oncology” 2008, nr 17. DOI:10.1002/pon.1313.

National Cancer Institute: Dictionary of Cancer Terms, 2019, https://www.cancer.gov/publications/dictionaries/cancerterms/def/survivorship.

Ogden J., Health Psychology, Open University Press, Berkshire 2012.

Okuyama T., Tanaka K., Akechi T., Kugaya A., Okamura H., Nishiwaki Y., Hosaka T., Uchitomi Y., Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening, „J Pain Symptom Manag” 2001, nr 22.

Praško J., Úzkostné poruchy, Portál, Praha 2005.

Spiegel D., Riba M.B., Psychological Issues in Cancer, [w:] V.T. DeVita, T.S. Lawrence, S.A. Rosenberg (red.), Cancer: Principles & Practice of Oncology, Wolters Kluwer Health, Lippincott Williams & Wilkins, Philadelphia 2011.

Stark D.P.H., House A., Anxiety in cancer patients, „British Journal of Cancer” 2000, Vol. 83, No. 10.

Spitzer R.L., Kroenke K., Williams J.B., Löwe B., A brief measure for assessing generalized anxiety disorder: the GAD-7, „Archives of Internal Medicine” 2006, Vol. 66, No. 10.

Trask P.C., Assessment of Depression in Cancer Patients, „Journal of the National Cancer Institute Monographs” 2004, nr 32.

Ullman K., Cancer Survivorship Gains Importance, “JNCI” 2014, Vol. 106, No. 1. DOI:10.1093/jnci/djt450.

Watson M., Greer S., Rowden L., Gorman C., Robertson B., Bliss J.M., Tunmore R., Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients, „Psychol Med.” 1991, nr 21.

Watson D., Clark L.A., Carey G., Positive and Negative Affectivity and Their Relation to Anxiety and Depresive Disorders, „Journal of Abnormal Psychology” 1988, Vol. 97, No. 3.

Valkučáková V., Psychiatrická pomoc pri onkologických ochoreniach, “Krvinka” 2016, nr 1.

Van Esch L., Roukema J.A., Ernst M.F., Nieuwenhuijzen G.A.P., De Vries J., Combined anxiety and depressive symptoms before diagnosis of breast cancer, „Journal of Affective Disorders” 2012, nr 136. DOI: 10.1016/j.jad.2011.09.012.

Zaorsky N.G., Zhang Y., Tuanquin L., Bleuthmann Sh.M., Pork HS., Chinchilli V.M., Suicide among cancer patients, „Nature communications” 2019, Vol. 10, No. 27. DOI: 10.1038/s41467-018-08170-1.